Rani Therapeutics Holdings, Inc.
RANI· Nasdaq
Released Mar 26, 2026, after the close
10-K filed Mar 26, 2026, 85 days after period end · 0001193125-26-126417
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.46M | $1.03M | — | — |
| Net Income | -$10.31M |
Rani Therapeutics Holdings, Inc. · CIK 1856725 · Engraved from SEC EDGAR
| -$8.95M |
| -$7.10M |
| -$8.79M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.